NeuroOne Medical Technologies Corp (NAS:NMTC)

Q2 2026 NeuroOne Medical Technologies Corp Earnings Call Transcript

May 12, 2026 / 12:30 PM GMT

Release Date Price: $4.39 (+1.39%)

Transcript 10-Q8-K

Key Points

Positve

Product revenue for the 1RF brain ablation system grew 72% year-over-year to $2.4 million.
NeuroOne Medical Technologies Corp (NMTC) regained compliance with Nasdaq's minimum bid price requirement.
The company completed the Stage 2 audit for ISO 13,485 certification, paving the way for international distribution.
The 1RF trigeminal nerve ablation system has shown clinical success, with all patients reportedly pain-free after procedures.
NeuroOne Medical Technologies Corp (NMTC) announced a collaboration with the University of Minnesota Medical School to advance epilepsy therapies using their drug delivery platform.

Negative

The company had no license revenue in the second quarter or first six months of fiscal 2026, compared to $3 million in the first six months of fiscal 2025.
Product gross profit margin decreased to 53.8% from 55.6% in the same quarter of the prior fiscal year.
Net loss in the second quarter of fiscal 2026 was $2.1 million, compared to a net loss of $2.3 million in the same quarter of the prior year.
Cash and cash equivalents decreased to $2.8 million as of March 31, 2026, from $6.6 million as of September 30, 2025.
The company has not yet finalized a commercialization strategy for its drug delivery program, which is expected to be available in the latter half of fiscal 2026.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NMTC.OQ - Neuroone Medical Technologies Corp
Q2 2026 NeuroOne Medical Technologies Corp Earnings Call
May 12, 2026 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day, ladies and gentlemen, and welcome to NeuroOne Medical Technologies Corporation's Second Quarter Fiscal 2026 Financial Results Conference Call.

Today's call will be conducted by the company's Chief Executive Officer, Dave Rosa, and Ron McClure, the company's Chief Financial Officer.

Before I turn the call over to Mr. Rosa, I'd like to remind you that this conference call will include forward-looking statements. Within the meaning of U.S. Federal securities laws with respect to future operations, financial results, including events, trends, and performance, which are based on management's beliefs and assumptions as of today's call.

Forward-looking statements may involve

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.